New Method Tracks the 'Learning Curve' of AI to Decode Complex Genomic Data

Introducing Annotatability - a powerful new framework to address a major challenge in biological research by examining how artificial neural networks learn to label genomic data. Genomic datasets often contain vast amounts of annotated samples, but many of these samples are annotated either incorrectly or ambiguously. Borrowing from recent advances in the fields of natural language processing and computer vision, the team used artificial neural networks (ANNs) in a non-conventional way: instead of merely using the ANNs to make predictions, the group inspected the difficulty with which they learned to label different biological samples. Somewhat similarly to assessing why students find some examples harder than others, the team then leveraged this unique source of information to identify mismatches in cell annotations, improve data interpretation, and uncover key cellular pathways linked to development and disease. Annotatability provides a more accurate method for analyzing genomic data on single cells, offering significant potential for advancing biological research, and in the longer term, improving disease diagnosis and treatment.

A new study led by Jonathan Karin, Reshef Mintz, Dr. Barak Raveh and Dr. Mor Nitzan from Hebrew University, published in Nature Computational Science, introduces a new framework for interpreting single-cell and spatial omics data by monitoring deep neural networks training dynamics. The research aims to address the inherent ambiguities in cell annotations and offers a novel approach for understanding complex biological data.

Single-cell and spatial omics data have transformed our ability to explore cellular diversity and cellular behaviors in health and disease. However, the interpretation of these high-dimensional datasets is challenging, primarily due to the difficulty of assigning discrete and accurate annotations, such as cell types or states, to heterogeneous cell populations. These annotations are often subjective, noisy, and incomplete, making it difficult to extract meaningful insights from the data.

The researchers developed a new framework, Annotatability, which helps identify mismatches in cell annotations and better characterizes biological data structures. By monitoring the dynamics and difficulty of training a deep neural network over annotated data, Annotatability identifies areas where cell annotations are ambiguous or erroneous. The approach also highlights intermediate cell states and the complex, continuous nature of cellular development.

As part of the study, the team introduced a signal-aware graph embedding method that enables more precise downstream analysis of biological signals. This technique captures cellular communities associated with target signals and facilitates the exploration of cellular heterogeneity, developmental pathways, and disease trajectories.

The study demonstrates the applicability of Annotatability across a range of single-cell RNA sequencing and spatial omics datasets. Notable findings include the identification of erroneous annotations, delineation of developmental and disease-related cell states, and better characterization of cellular heterogeneity. The results highlight the potential of this framework for unraveling complex cellular behaviors and advancing our understanding of both health and disease at the single-cell level.

The researchers' work presents a significant step forward in genomic data interpretation, offering a powerful tool for unraveling cellular diversity and enhancing our ability to study the dynamics of health and disease.

Karin J, Mintz R, Raveh B, Nitzan M.
Interpreting single-cell and spatial omics data using deep neural network training dynamics.
Nat Comput Sci. 2024 Dec;4(12):941-954. doi: 10.1038/s43588-024-00721-5

Most Popular Now

Research Shows AI Technology Improves Pa…

Existing research indicates that the accuracy of a Parkinson's disease diagnosis hovers between 55% and 78% in the first five years of assessment. That's partly because Parkinson's sibling movement disorders...

AI in Healthcare: How do We Get from Hyp…

The Highland Marketing advisory board met to consider the government's enthusiasm for AI. To date, healthcare has mostly experimented with decision support tools, and their impact on the NHS and...

Who's to Blame When AI Makes a Medi…

Assistive artificial intelligence technologies hold significant promise for transforming health care by aiding physicians in diagnosing, managing, and treating patients. However, the current trend of assistive AI implementation could actually...

First Therapy Chatbot Trial Shows AI can…

Dartmouth researchers conducted the first clinical trial of a therapy chatbot powered by generative AI and found that the software resulted in significant improvements in participants' symptoms, according to results...

DMEA sparks: The Future of Digital Healt…

8 - 10 April 2025, Berlin, Germany. Digitalization is considered one of the key strategies for addressing the shortage of skilled workers - but the digital health sector also needs qualified...

DeepSeek: The "Watson" to Doct…

DeepSeek is an artificial intelligence (AI) platform built on deep learning and natural language processing (NLP) technologies. Its core products include the DeepSeek-R1 and DeepSeek-V3 models. Leveraging an efficient Mixture...

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...